ProShares Ultra Bloomberg Natural Gas

Direxion Daily FTSE China Bull 3X ETF

Volatility Shares Trust 2x Ether ETF

United States Natural Gas

Direxion Daily TSLA Bull 1.5X Shares

Direxion Daily Semicondct Bear 3X ETF

ARK Genomic Revolution Multi-Sector ETF

iShares Barclays TIPS Bond Fund

Global X Uranium ETF

Mast Therapeutics, Inc.

ProShares UltraShort Bloomberg Natrl Gas

Exchange Traded Concepts Trust Range Global Coal Index ETF

Direxion Daily Semicondct Bull 3X ETF

iShares Ethereum Trust ETF

T-REX 2X Inverse Tesla Daily Target ETF

iPath S&P 500 VIX ST Futures ETN

Direxion Daily 20+ Yr Trsy Bull 3X ETF

ProShares UltraShort Silver

ProShares Ultra Semiconductors

Direxion Daily Technology Bull 3X ETF

Siyata Mobile Inc. Common Shares

Eyenovia Inc. Common Stock

Edible Garden AG Incorporated Common Stock

D-Wave Quantum Inc. Common Shares

MicroAlgo Inc. Ordinary Shares

LOBO EV TECHNOLOGIES LTD. Ordinary shares

Pegasystems Inc. Common Stock

Rigetti Computing Inc. Common Stock

ScanTech AI Systems Inc. Common stock

Green Plains Inc. Common Stock

Protagenic Therapeutics Inc. Common Stock

Brainstorm Cell Therapeutics Inc. Common Stock

Incannex Healthcare Limited American Depositary Shares

iCoreConnect Inc. Common stock

Dycom Industries Inc. Common Stock

Aytu BioPharma Inc.  Common Stock

Ingersoll Rand Inc. Common Stock

SCWorx Corp. Common Stock

Paychex Inc. Common Stock

UBS Group AG Registered Ordinary Shares

Click here to get full coverage on Why Intra-Cellular Therapies (ITCI) Is Skyrocketing Now - Yahoo Finance

Why Intra-Cellular Therapies (ITCI) Is Skyrocketing Now  Yahoo Finance

Why Intra-Cellular Therapies (ITCI) Is Skyrocketing Now - Yahoo Finance

Click here to get full coverage on Fund Update: HSBC HOLDINGS PLC opened a $33.5M position in $ITCI stock - Nasdaq

Fund Update: HSBC HOLDINGS PLC opened a $33.5M position in $ITCI stock  Nasdaq

Fund Update: HSBC HOLDINGS PLC opened a $33.5M position in $ITCI stock - Nasdaq

Click here to get full coverage on J&J to buy neurological drugmaker Intra-Cellular for $14.6 billion - CNBC

J&J to buy neurological drugmaker Intra-Cellular for $14.6 billion  CNBC

J&J to buy neurological drugmaker Intra-Cellular for $14.6 billion - CNBC

Click here to get full coverage on ITCI Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Intra-Cellular Therapies, Inc. Is Fair to Shareholders - Business Wire

ITCI Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Intra-Cellular Therapies, Inc. Is Fair to Shareholders  Business Wire

ITCI Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Intra-Cellular Therapies, Inc. Is Fair to Shareholders - Business Wire

Click here to get full coverage on Johnson & Johnson (JNJ) Closes Intra-Cellular Therapies, Inc. (ITCI) Acquisition - StreetInsider

Johnson & Johnson (JNJ) Closes Intra-Cellular Therapies, Inc. (ITCI) Acquisition  StreetInsider

Johnson & Johnson (JNJ) Closes Intra-Cellular Therapies, Inc. (ITCI) Acquisition - StreetInsider

Click here to get full coverage on BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of  GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire

Click here to get full coverage on Intra-Cellular Therapies (ITCI): Among the Best Biotech Stocks to Buy According to Billionaires - Yahoo Finance

Intra-Cellular Therapies (ITCI): Among the Best Biotech Stocks to Buy According to Billionaires  Yahoo Finance

Intra-Cellular Therapies (ITCI): Among the Best Biotech Stocks to Buy According to Billionaires - Yahoo Finance

Click here to get full coverage on ITCI Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Intra-cellular Therapies, Inc. Is Fair to Shareholders - Business Wire

ITCI Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Intra-cellular Therapies, Inc. Is Fair to Shareholders  Business Wire

ITCI Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Intra-cellular Therapies, Inc. Is Fair to Shareholders - Business Wire

Click here to get full coverage on Johnson & Johnson Strengthens Neuroscience Leadership with Acquisition of Intra-Cellular Therapies, Inc. - GlobeNewswire

Johnson & Johnson Strengthens Neuroscience Leadership with Acquisition of Intra-Cellular Therapies, Inc.  GlobeNewswire

Johnson & Johnson Strengthens Neuroscience Leadership with Acquisition of Intra-Cellular Therapies, Inc. - GlobeNewswire

Click here to get full coverage on ITCI Stock Surges 34% as J&J Reveals $14.6 Billion Acquisition Plan - Yahoo Finance

ITCI Stock Surges 34% as J&J Reveals $14.6 Billion Acquisition Plan  Yahoo Finance

ITCI Stock Surges 34% as J&J Reveals $14.6 Billion Acquisition Plan - Yahoo Finance

Click here to get full coverage on INTRA-CELLULAR THERAPIES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Intra-Cellular Therapies, Inc. - ITCI - Business Wire

INTRA-CELLULAR THERAPIES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Intra-Cellular Therapies, Inc. - ITCI  Business Wire

INTRA-CELLULAR THERAPIES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Intra-Cellular Therapies, Inc. - ITCI - Business Wire

Click here to get full coverage on Why Intra-Cellular Therapies, Inc. (ITCI) Is Skyrocketing Now - Yahoo Finance

Why Intra-Cellular Therapies, Inc. (ITCI) Is Skyrocketing Now  Yahoo Finance

Why Intra-Cellular Therapies, Inc. (ITCI) Is Skyrocketing Now - Yahoo Finance

Click here to get full coverage on ITCI Q4 Loss Wider Than Expected, Revenues Top on Higher Caplyta Sales - Yahoo Finance

ITCI Q4 Loss Wider Than Expected, Revenues Top on Higher Caplyta Sales  Yahoo Finance

ITCI Q4 Loss Wider Than Expected, Revenues Top on Higher Caplyta Sales - Yahoo Finance

Click here to get full coverage on Intra-Cellular Therapies (ITCI) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance

Intra-Cellular Therapies (ITCI) Reports Q4 Loss, Tops Revenue Estimates  Yahoo Finance

Intra-Cellular Therapies (ITCI) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance

Click here to get full coverage on When Will Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Turn A Profit? - Yahoo Finance

When Will Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Turn A Profit?  Yahoo Finance

When Will Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Turn A Profit? - Yahoo Finance

Click here to get full coverage on Pharma Stock Roundup: J&J's ITCI Buyout, LLY's Weak Q4 Sales - Yahoo Finance

Pharma Stock Roundup: J&J's ITCI Buyout, LLY's Weak Q4 Sales  Yahoo Finance

Pharma Stock Roundup: J&J's ITCI Buyout, LLY's Weak Q4 Sales - Yahoo Finance

Click here to get full coverage on Intra-Cellular (ITCI) Moves 34.1% Higher: Will This Strength Last? - Yahoo Finance

Intra-Cellular (ITCI) Moves 34.1% Higher: Will This Strength Last?  Yahoo Finance

Intra-Cellular (ITCI) Moves 34.1% Higher: Will This Strength Last? - Yahoo Finance

Click here to get full coverage on ITCI Stock Rises 15% on Settling Caplyta Patent Litigation With Sandoz - Yahoo Finance

ITCI Stock Rises 15% on Settling Caplyta Patent Litigation With Sandoz  Yahoo Finance

ITCI Stock Rises 15% on Settling Caplyta Patent Litigation With Sandoz - Yahoo Finance

Click here to get full coverage on Intra-Cellular Therapies Stock Up 34% on J&J's $14.6B Buyout Offer - Yahoo Finance

Intra-Cellular Therapies Stock Up 34% on J&J's $14.6B Buyout Offer  Yahoo Finance

Intra-Cellular Therapies Stock Up 34% on J&J's $14.6B Buyout Offer - Yahoo Finance

Click here to get full coverage on ITCI Submits sNDA to the FDA for Expanded Use of Caplyta in MDD - Yahoo Finance

ITCI Submits sNDA to the FDA for Expanded Use of Caplyta in MDD  Yahoo Finance

ITCI Submits sNDA to the FDA for Expanded Use of Caplyta in MDD - Yahoo Finance

Click here to get full coverage on Shareholder Alert: Ademi LLP investigates whether Intra-Cellular Therapies, Inc. is obtaining a Fair Price for its Public Shareholders - Business Wire

Shareholder Alert: Ademi LLP investigates whether Intra-Cellular Therapies, Inc. is obtaining a Fair Price for its Public Shareholders  Business Wire

Shareholder Alert: Ademi LLP investigates whether Intra-Cellular Therapies, Inc. is obtaining a Fair Price for its Public Shareholders - Business Wire

Click here to get full coverage on J&J Announces A Splashy $14.6 Billion Deal, While Lilly Tacks On A Cancer Drug - Investor's Business Daily

J&J Announces A Splashy $14.6 Billion Deal, While Lilly Tacks On A Cancer Drug  Investor's Business Daily

J&J Announces A Splashy $14.6 Billion Deal, While Lilly Tacks On A Cancer Drug - Investor's Business Daily

Click here to get full coverage on J&J doubles down on neurological drugs with $14.6 billion Intra-Cellular deal - Reuters

J&J doubles down on neurological drugs with $14.6 billion Intra-Cellular deal  Reuters

J&J doubles down on neurological drugs with $14.6 billion Intra-Cellular deal - Reuters

Click here to get full coverage on Intra-Cellular Therapies Stock Pops as Johnson & Johnson Buys Firm for $14.6B - Investopedia

Intra-Cellular Therapies Stock Pops as Johnson & Johnson Buys Firm for $14.6B  Investopedia

Intra-Cellular Therapies Stock Pops as Johnson & Johnson Buys Firm for $14.6B - Investopedia

Click here to get full coverage on Johnson & Johnson: No More Tears, Just Gains In Intra-Cellular Acquisition - Seeking Alpha

Johnson & Johnson: No More Tears, Just Gains In Intra-Cellular Acquisition  Seeking Alpha

Johnson & Johnson: No More Tears, Just Gains In Intra-Cellular Acquisition - Seeking Alpha

Click here to get full coverage on Intra-Cellular Therapies Soars 32% With Johnson & Johnson's $14.6B Acquisition - Yahoo Finance

Intra-Cellular Therapies Soars 32% With Johnson & Johnson's $14.6B Acquisition  Yahoo Finance

Intra-Cellular Therapies Soars 32% With Johnson & Johnson's $14.6B Acquisition - Yahoo Finance

Click here to get full coverage on Intra-Cellular Therapies Completes Merger with Johnson & Johnson - TipRanks

Intra-Cellular Therapies Completes Merger with Johnson & Johnson  TipRanks

Intra-Cellular Therapies Completes Merger with Johnson & Johnson - TipRanks

Click here to get full coverage on Intra-Cellular Therapies Settles CAPLYTA® (lumateperone) Patent Litigation with Sandoz - GlobeNewswire

Intra-Cellular Therapies Settles CAPLYTA® (lumateperone) Patent Litigation with Sandoz  GlobeNewswire

Intra-Cellular Therapies Settles CAPLYTA® (lumateperone) Patent Litigation with Sandoz - GlobeNewswire

Click here to get full coverage on Intra-Cellular Therapies acquired by Johnson & Johnson for $14.6 billion - Investing.com

Intra-Cellular Therapies acquired by Johnson & Johnson for $14.6 billion  Investing.com

Intra-Cellular Therapies acquired by Johnson & Johnson for $14.6 billion - Investing.com

Click here to get full coverage on JNJ forecasts 2025 profit dilution from Intra-Cellular deal, sets closing date - Seeking Alpha

JNJ forecasts 2025 profit dilution from Intra-Cellular deal, sets closing date  Seeking Alpha

JNJ forecasts 2025 profit dilution from Intra-Cellular deal, sets closing date - Seeking Alpha

Click here to get full coverage on Peaking Back In On Intra-Cellular Therapies (NASDAQ:ITCI) - Seeking Alpha

Peaking Back In On Intra-Cellular Therapies (NASDAQ:ITCI)  Seeking Alpha

Peaking Back In On Intra-Cellular Therapies (NASDAQ:ITCI) - Seeking Alpha

Click here to get full coverage on Biggest stock movers Monday: Cryptocurrency-linked stocks, MRNA, ITCI, and more - MSN

Biggest stock movers Monday: Cryptocurrency-linked stocks, MRNA, ITCI, and more  MSN

Biggest stock movers Monday: Cryptocurrency-linked stocks, MRNA, ITCI, and more - MSN

Click here to get full coverage on Intra-Cellular Therapies, Inc. (ITCI): Among the Best Psychedelic Stocks to Buy in 2025 - Yahoo

Intra-Cellular Therapies, Inc. (ITCI): Among the Best Psychedelic Stocks to Buy in 2025  Yahoo

Intra-Cellular Therapies, Inc. (ITCI): Among the Best Psychedelic Stocks to Buy in 2025 - Yahoo

Click here to get full coverage on Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2024 Financial Results - GlobeNewswire

Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2024 Financial Results  GlobeNewswire

Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2024 Financial Results - GlobeNewswire

Click here to get full coverage on What Johnson & Johnson Is Getting With The Acquisition Of Intra-Cellular Therapies (ITCI) - Seeking Alpha

What Johnson & Johnson Is Getting With The Acquisition Of Intra-Cellular Therapies (ITCI)  Seeking Alpha

What Johnson & Johnson Is Getting With The Acquisition Of Intra-Cellular Therapies (ITCI) - Seeking Alpha

Click here to get full coverage on JPMorgan Chase & Co's Strategic Acquisition of Shares in Intra-Cellular Therapies Inc - Yahoo Finance

JPMorgan Chase & Co's Strategic Acquisition of Shares in Intra-Cellular Therapies Inc  Yahoo Finance

JPMorgan Chase & Co's Strategic Acquisition of Shares in Intra-Cellular Therapies Inc - Yahoo Finance

Click here to get full coverage on J&J Bolsters Its Prospects in Brain Health With $14B Buyout of Intra-Cellular Therapies - MedCity News

J&J Bolsters Its Prospects in Brain Health With $14B Buyout of Intra-Cellular Therapies  MedCity News

J&J Bolsters Its Prospects in Brain Health With $14B Buyout of Intra-Cellular Therapies - MedCity News

Click here to get full coverage on Trend Tracker for (ITCI) - news.stocktradersdaily.com

Trend Tracker for (ITCI)  news.stocktradersdaily.com

Trend Tracker for (ITCI) - news.stocktradersdaily.com

Click here to get full coverage on Intra-Cellular Therapies progresses in Johnson & Johnson merger - Investing.com

Intra-Cellular Therapies progresses in Johnson & Johnson merger  Investing.com

Intra-Cellular Therapies progresses in Johnson & Johnson merger - Investing.com

Click here to get full coverage on J&J punts $14.6 billion on buy of Intra-Cellular Therapies - The Pharma Letter

J&J punts $14.6 billion on buy of Intra-Cellular Therapies  The Pharma Letter

J&J punts $14.6 billion on buy of Intra-Cellular Therapies - The Pharma Letter

Click here to get full coverage on J&J explores bid for Intra-Cellular Therapies, Bloomberg News reports - Reuters

J&J explores bid for Intra-Cellular Therapies, Bloomberg News reports  Reuters

J&J explores bid for Intra-Cellular Therapies, Bloomberg News reports - Reuters

Click here to get full coverage on RBC buyers of Intra-Cellular after ‘more favorable-than-expected’ settlement - Yahoo Finance

RBC buyers of Intra-Cellular after ‘more favorable-than-expected’ settlement  Yahoo Finance

RBC buyers of Intra-Cellular after ‘more favorable-than-expected’ settlement - Yahoo Finance

Click here to get full coverage on Intra-Cellular Therapies Stock Is Surging Monday: What's Going On? - Benzinga

Intra-Cellular Therapies Stock Is Surging Monday: What's Going On?  Benzinga

Intra-Cellular Therapies Stock Is Surging Monday: What's Going On? - Benzinga

Click here to get full coverage on Intra-Cellular Therapies Shareholders Approve Johnson & Johnson Merger - Investing.com

Intra-Cellular Therapies Shareholders Approve Johnson & Johnson Merger  Investing.com

Intra-Cellular Therapies Shareholders Approve Johnson & Johnson Merger - Investing.com

Click here to get full coverage on Intra-Cellular Therapies announces proxy statement supplement - Investing.com

Intra-Cellular Therapies announces proxy statement supplement  Investing.com

Intra-Cellular Therapies announces proxy statement supplement - Investing.com

Click here to get full coverage on Where are the Opportunities in (ITCI) - news.stocktradersdaily.com

Where are the Opportunities in (ITCI)  news.stocktradersdaily.com

Where are the Opportunities in (ITCI) - news.stocktradersdaily.com

Click here to get full coverage on Johnson & Johnson (JNJ) to Acquire Intra-Cellular Therapies (ITCI) for $14.6 Billion - GuruFocus

Johnson & Johnson (JNJ) to Acquire Intra-Cellular Therapies (ITCI) for $14.6 Billion  GuruFocus

Johnson & Johnson (JNJ) to Acquire Intra-Cellular Therapies (ITCI) for $14.6 Billion - GuruFocus

Click here to get full coverage on ITCI Q4 Loss Wider Than Expected, Revenues Top on Higher Caplyta Sales - MSN

ITCI Q4 Loss Wider Than Expected, Revenues Top on Higher Caplyta Sales  MSN

ITCI Q4 Loss Wider Than Expected, Revenues Top on Higher Caplyta Sales - MSN

Click here to get full coverage on J&J CEO broke a stalemate and facilitated the $14.6B Intra-Cellular buyout in a whirlwind month: filing - Fierce Pharma

J&J CEO broke a stalemate and facilitated the $14.6B Intra-Cellular buyout in a whirlwind month: filing  Fierce Pharma

J&J CEO broke a stalemate and facilitated the $14.6B Intra-Cellular buyout in a whirlwind month: filing - Fierce Pharma

Click here to get full coverage on J&J buys Intra-Cellular in $14.6 billion deal, delving further into central nervous system disorders - Yahoo Finance

J&J buys Intra-Cellular in $14.6 billion deal, delving further into central nervous system disorders  Yahoo Finance

J&J buys Intra-Cellular in $14.6 billion deal, delving further into central nervous system disorders - Yahoo Finance

Click here to get full coverage on Intra-Cellular Therapies to Present at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewswire

Intra-Cellular Therapies to Present at the 43rd Annual J.P. Morgan Healthcare Conference  GlobeNewswire

Intra-Cellular Therapies to Present at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewswire

Click here to get full coverage on Intra-Cellular Therapies Stock Surges After J&J Agrees to Buy Drug Maker - WSJ

Intra-Cellular Therapies Stock Surges After J&J Agrees to Buy Drug Maker  WSJ

Intra-Cellular Therapies Stock Surges After J&J Agrees to Buy Drug Maker - WSJ

Click here to get full coverage on J&J to Acquire Intra-Cellular for About $14.6 Billion - Bloomberg

J&J to Acquire Intra-Cellular for About $14.6 Billion  Bloomberg

J&J to Acquire Intra-Cellular for About $14.6 Billion - Bloomberg

Click here to get full coverage on ITCI Poised for Turnaround Amid Rising Mental Health Concerns - GuruFocus

ITCI Poised for Turnaround Amid Rising Mental Health Concerns  GuruFocus

Intracellular Th (ITCI)

Price Chart

Key Statistics

Technicals

About ITCI

Latest News

Why Intra-Cellular Therapies (ITCI) Is Skyrocketing Now - Yahoo Finance

Fund Update: HSBC HOLDINGS PLC opened a $33.5M position in $ITCI stock - Nasdaq

J&J to buy neurological drugmaker Intra-Cellular for $14.6 billion - CNBC

Advanced Charts

Top Gainers

Top Losers